297 related articles for article (PubMed ID: 15681522)
1. Breast cancer treatment guidelines in older women.
Giordano SH; Hortobagyi GN; Kau SW; Theriault RL; Bondy ML
J Clin Oncol; 2005 Feb; 23(4):783-91. PubMed ID: 15681522
[TBL] [Abstract][Full Text] [Related]
2. Improving local control with breast-conserving therapy: a 27-year single-institution experience.
Cabioglu N; Hunt KK; Buchholz TA; Mirza N; Singletary SE; Kuerer HM; Babiera GV; Ames FC; Sahin AA; Meric-Bernstam F
Cancer; 2005 Jul; 104(1):20-9. PubMed ID: 15912514
[TBL] [Abstract][Full Text] [Related]
3. Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma: evidence from a tertiary care cohort of chemotherapy-eligible patients.
DeMichele A; Putt M; Zhang Y; Glick JH; Norman S
Cancer; 2003 May; 97(9):2150-9. PubMed ID: 12712466
[TBL] [Abstract][Full Text] [Related]
4. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
[TBL] [Abstract][Full Text] [Related]
5. Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women.
Hébert-Croteau N; Brisson J; Latreille J; Blanchette C; Deschênes L
Cancer; 1999 Mar; 85(5):1104-13. PubMed ID: 10091795
[TBL] [Abstract][Full Text] [Related]
6. Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer.
Hershman DL; Buono D; McBride RB; Tsai WY; Joseph KA; Grann VR; Jacobson JS
J Natl Cancer Inst; 2008 Feb; 100(3):199-206. PubMed ID: 18230795
[TBL] [Abstract][Full Text] [Related]
7. Retrospective study of the effect of comorbidity on use of adjuvant chemotherapy in older women with breast cancer in a tertiary care setting.
Hawfield A; Lovato J; Covington D; Kimmick G
Crit Rev Oncol Hematol; 2006 Sep; 59(3):250-5. PubMed ID: 16527489
[TBL] [Abstract][Full Text] [Related]
8. Treatment trends and factors associated with survival in T1aN0 and T1bN0 breast cancer patients.
Kennedy T; Stewart AK; Bilimoria KY; Patel-Parekh L; Sener SF; Winchester DP
Ann Surg Oncol; 2007 Oct; 14(10):2918-27. PubMed ID: 17638060
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort.
Elkin EB; Hurria A; Mitra N; Schrag D; Panageas KS
J Clin Oncol; 2006 Jun; 24(18):2757-64. PubMed ID: 16782916
[TBL] [Abstract][Full Text] [Related]
10. Effect of undertreatment on the disparity in age-related breast cancer-specific survival among older women.
Owusu C; Lash TL; Silliman RA
Breast Cancer Res Treat; 2007 Apr; 102(2):227-36. PubMed ID: 17004115
[TBL] [Abstract][Full Text] [Related]
11. Receipt of appropriate primary breast cancer therapy and adjuvant therapy are not associated with obesity in older women with access to health care.
Buist DS; Ichikawa L; Prout MN; Yood MU; Field TS; Owusu C; Geiger AM; Quinn VP; Wei F; Silliman RA
J Clin Oncol; 2007 Aug; 25(23):3428-36. PubMed ID: 17687148
[TBL] [Abstract][Full Text] [Related]
12. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
Mariotto AB; Feuer EJ; Harlan LC; Abrams J
J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
[TBL] [Abstract][Full Text] [Related]
13. Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000.
Harlan LC; Clegg LX; Abrams J; Stevens JL; Ballard-Barbash R
J Clin Oncol; 2006 Feb; 24(6):872-7. PubMed ID: 16484696
[TBL] [Abstract][Full Text] [Related]
14. Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens.
Griggs JJ; Culakova E; Sorbero ME; Poniewierski MS; Wolff DA; Crawford J; Dale DC; Lyman GH
J Clin Oncol; 2007 Jun; 25(18):2522-7. PubMed ID: 17577029
[TBL] [Abstract][Full Text] [Related]
15. Association of surgery with improved survival in stage IV breast cancer patients.
Blanchard DK; Shetty PB; Hilsenbeck SG; Elledge RM
Ann Surg; 2008 May; 247(5):732-8. PubMed ID: 18438108
[TBL] [Abstract][Full Text] [Related]
16. Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy.
Huang EH; Tucker SL; Strom EA; McNeese MD; Kuerer HM; Hortobagyi GN; Buzdar AU; Valero V; Perkins GH; Schechter NR; Hunt KK; Sahin AA; Buchholz TA
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):351-7. PubMed ID: 15890574
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
[TBL] [Abstract][Full Text] [Related]
18. Breast conservation surgery achieving>or=2 mm tumor-free margins results in decreased local-regional recurrence rates.
Kunos C; Latson L; Overmoyer B; Silverman P; Shenk R; Kinsella T; Lyons J
Breast J; 2006; 12(1):28-36. PubMed ID: 16409584
[TBL] [Abstract][Full Text] [Related]
19. [Effective treatment strategy in elderly breast cancer patients].
Boér K
Orv Hetil; 2005 Jan; 146(1):15-21. PubMed ID: 15715368
[TBL] [Abstract][Full Text] [Related]
20. Older women with breast carcinoma are less likely to receive adjuvant chemotherapy: evidence of possible age bias?
Woodard S; Nadella PC; Kotur L; Wilson J; Burak WE; Shapiro CL
Cancer; 2003 Sep; 98(6):1141-9. PubMed ID: 12973837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
